Track topics on Twitter Track topics that are important to you
A novel Occlutech atrial flow regulator (AFR) implantation gives an atrial septal predefined predictable fenestration.
This study aims to investigate safety and efficacy of Occlutech® AFR device in patients with HFrEF (Heart failure with reduced ejection fraction) and HFpEF (Heart failure with preserved e...
This is a prospective, non-randomized, study of the safety and efficacy of the Occlutech® LAA occluder indicated for percutaneous LAA closure in adult male or female patients with atrial...
Collect patient data and to monitor the clinical use (safety and efficacy) of the device
Aim of this prospective trial is to assess the hemodynamic effects of a MitraClip procedure caused iatrogenic arterial septal defect (iASD) and the functional changes after interventional ...
We have published hundreds of Occlutech AG news stories on BioPortfolio along with dozens of Occlutech AG Clinical Trials and PubMed Articles about Occlutech AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Occlutech AG Companies in our database. You can also find out about relevant Occlutech AG Drugs and Medications on this site too.